AMYLIN PHARMACEUTICALS INC Stock-Based Compensation
AMYLIN PHARMACEUTICALS INC reported Stock-Based Compensation of $7.21 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $7.21M, a 9.37% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $9.16M, a 15.68% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $9.20M, a 4.63% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $7.41M, a 5.41% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $32.47M, a 9.86% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $36.02M, a 17.69% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2009 was $43.76M, a 20.60% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2008 was $55.12M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2012-06-30 | $7.21M 10-Q · filed 2012-08-03 | $16.36M 10-Q · filed 2012-08-03 | $25.56M derived: sum of 3 quarters · filed 2012-08-03 | $32.97M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2012-03-31 | $9.16M 10-Q · filed 2012-05-07 | $18.35M derived: sum of 2 quarters · filed 2012-05-07 | $25.76M derived: sum of 3 quarters · filed 2012-05-07 | $33.72M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-12-31 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $16.61M derived: sum of 2 quarters · filed 2012-02-22 | $24.56M derived: sum of 3 quarters · filed 2012-08-03 | $32.47M 10-K · filed 2012-02-22 | |
| 2011-09-30 | $7.41M 10-Q · filed 2011-10-28 | $15.36M derived: sum of 2 quarters · filed 2012-08-03 | $23.28M 10-Q · filed 2011-10-28 | $32.07M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-06-30 | $7.95M 10-Q · filed 2012-08-03 | $7.95M 10-Q · filed 2011-08-08 | $15.87M 10-Q · filed 2012-08-03 | $24.66M derived: sum of 3 quarters · filed 2012-08-03 | $31.69M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $7.92M 10-Q · filed 2012-05-07 | $16.70M derived: sum of 2 quarters · filed 2012-05-07 | $23.73M derived: sum of 3 quarters · filed 2012-05-07 | $34.24M derived: sum of 4 quarters · filed 2012-05-07 | |
| 2010-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $15.82M derived: sum of 2 quarters · filed 2012-02-22 | $26.32M derived: sum of 3 quarters · filed 2012-02-22 | $36.02M 10-K · filed 2012-02-22 | |
| 2010-09-30 | $7.03M 10-Q · filed 2011-10-28 | $17.53M derived: sum of 2 quarters · filed 2011-10-28 | $27.23M 10-Q · filed 2011-10-28 | $37.05M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-06-30 | $10.50M 10-Q · filed 2011-08-08 | $20.20M 10-Q · filed 2011-08-08 | $30.02M derived: sum of 3 quarters · filed 2012-02-22 | $40.92M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-03-31 | $9.70M 10-Q · filed 2011-05-05 | $19.52M derived: sum of 2 quarters · filed 2012-02-22 | $30.42M derived: sum of 3 quarters · filed 2012-02-22 | ||
| 2009-12-31 | $9.81M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $20.71M derived: sum of 2 quarters · filed 2012-02-22 | $43.76M 10-K · filed 2012-02-22 | ||
| 2009-09-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $33.95M 10-Q · filed 2010-11-08 | |||
| 2009-06-30 | $23.05M 10-Q · filed 2010-08-05 | ||||
| 2008-12-31 | $55.12M 10-K · filed 2011-02-25 |